New Delhi: A day after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting permission for emergency use of the Oxford vaccine, the expert panel on Saturday gave similar direction for the indigenously developed coronavirus vaccine Covaxin with certain conditions.
Bharat Biotech, which has developed Covaxin in collaboration with Indian Council of Medical Research (ICMR), had applied to the Drugs Controller General Of India (DCGI) seeking emergency use authorisation (EUA) for its Covaxin on December 7.
The expert committee, which had asked for further data on its phase 3 trials, again deliberated on emergency use application of the Hyderabad-based pharma company after they submitted additional data, facts and analysis, The Indian Express reported.
Also Read: Govt Panel Okays Oxford Vaccine In India, DCGI To Take Final Call On Rollout
Also Read: After Pfizer & SII, Bharat Biotech Too Seeks Emergency Use Approval For Covaxin
Also Read: Covaxin Capable Of Dealing With New COVID Strains, Says Bharat Biotech Chairman
New Delhi/Bhubaneswar: Tuhin Kanta Pandey, 1987-batch IAS officer of Odisha cadre, was on Monday assigned…
Bhubaneswar: The opening date of Bhubaneswar and Cuttack Bali Jatras this year face a clash…
Bhubaneswar: A recent study has warned that humans and animals will be wiped out from…
Mumbai: Ever since ‘Pushpa 2: The Rule’ went on floors, speculation was rife that ‘Stree…
Kolkata: Sanjay Roy, the prime suspect in the brutal rape and murder of a Kolkata…
Bhubaneswar: Vigilance officials seized suspected ill-gotten money amounting to Rs 2.8 lakh from an official…
Baripada: A man was saved from drowning in a deep well due to timely rescue…
Mumbai: Actor Arjun Kapoor, who joined the third instalment of Rohit Shetty’s cop universe franchise…